  Discovering imaging biomarkers for autism spectrum disorder (ASD) is critical
to help explain ASD and predict or monitor treatment outcomes. Toward this end,
deep learning classifiers have recently been used for identifying ASD from
functional magnetic resonance imaging (fMRI) with higher accuracy than
traditional learning strategies. However, a key challenge with deep learning
models is understanding just what image features the network is using, which
can in turn be used to define the biomarkers. Current methods extract
biomarkers, i.e., important features, by looking at how the prediction changes
if "ignoring" one feature at a time. In this work, we go beyond looking at only
individual features by using Shapley value explanation (SVE) from cooperative
game theory. Cooperative game theory is advantageous here because it directly
considers the interaction between features and can be applied to any machine
learning method, making it a novel, more accurate way of determining
instance-wise biomarker importance from deep learning models. A barrier to
using SVE is its computational complexity: $2^N$ given $N$ features. We
explicitly reduce the complexity of SVE computation by two approaches based on
the underlying graph structure of the input data: 1) only consider the
centralized coalition of each feature; 2) a hierarchical pipeline which first
clusters features into small communities, then applies SVE in each community.
Monte Carlo approximation can be used for large permutation sets. We first
validate our methods on the MNIST dataset and compare to human perception.
Next, to insure plausibility of our biomarker results, we train a Random Forest
(RF) to classify ASD/control subjects from fMRI and compare SVE results to
standard RF-based feature importance. Finally, we show initial results on
ranked fMRI biomarkers using SVE on a deep learning classifier for the
ASD/control dataset.
